Low-dose proton beam therpay for circumscibed choroidal hemangiomas
LONG-TERM RESULTS OF LOW-DOSE PROTON BEAM THERAPY FOR CIRCUMSCRIBED CHOROIDAL HEMANGIOMAS, from the February issue of Retina.
AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill
November 28th 2023At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.